INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 458m ago
House PTR58m ago
SEC 13F58m ago
Robinhood Chain58m ago

Results

76,508 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$268K
1,311 sh
May 7, 2026May 11, 2026
Page 980 of 1913
← PrevNext →
traded May 7, 2026
+4d
SEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$333K
1,640 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$605K
3,104 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$444K
2,288 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$362K
1,804 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$436K
2,182 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$900K
4,568 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$912K
4,725 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$640K
3,146 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$343K
1,696 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$436K
2,182 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$444K
2,287 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$362K
1,804 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$551K
2,702 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$605K
3,104 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

14
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$343K
1,696 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
FD
Fontaine DaniellePrincipal Accounting Officer
NOWServiceNow, Inc.
Option exercise
M—
305 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
846 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

13
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
30.0K sh
May 1, 2026May 11, 2026
traded May 1, 2026
+10dSEC Form 4

Evidence

13
AB
Adler BrookeSecretary
ACICAMERICAN COASTAL INSURANCE Corp
Option exercise
M—
11.2K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
ZA
Zavery AmitPresident, CPO and COO
NOWServiceNow, Inc.
Option exercise
M—
9,990 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
ZA
Zegna di Monte Rubello AngeloCo-CEO of the ZEGNA brand
ZGNErmenegildo Zegna N.V.
Option exercise
M—
15.6K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
ZE
Zegna di Monte Rubello EdoardoCo-CEO of the ZEGNA brand
ZGNErmenegildo Zegna N.V.
Option exercise
M—
31.5K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
AR
Agbede RobertDirector
CNXCNX Resources Corp
Grant or award
A—
5,568 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
MR
Matlock RobinDirector
IRMIRON MOUNTAIN INC
Grant or award
A—
1,892 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,405
117 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

13
SH
Sarrazin HugoDirector, President and CEO
UDMYUdemy, Inc.
Grant or award
A—
168.8K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

13
RR
Rosenthal RobertPresident, Udemy Business
UDMYUdemy, Inc.
Grant or award
A—
68.8K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

13
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$7,841
284 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

12
ZG
Zernick Thomas GerardDirector
BAFNBayFirst Financial Corp.
Other acquisition or disposition
J$1,500
227 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

12
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Other acquisition or disposition
J$300
45 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

12
AR
Atwood Catherine RSVP and General Counsel
RMRegional Management Corp.
Open-market sale · 10b5-1 plan
SELL$105K
3,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

12
MJ
McKim Scott JosephEVP, Chief Financial Officer
BAFNBayFirst Financial Corp.
Other acquisition or disposition
J$300
45 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$180K
914 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$183K
946 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
682 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$110K
541 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
586 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$198K
960 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

11
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$182K
945 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence